webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Glycan Drug Conjugate Service

Our Glycan Drug Conjugate service is designed to provide researchers, biotech companies, and pharmaceutical developers with end-to-end support in creating tailored glycan-drug constructs. From custom glycan synthesis and functionalization to precise drug payload attachment and rigorous analytical validation, we ensure every conjugate is reliable, reproducible, and optimized for biological performance. By combining state-of-the-art conjugation chemistries with a diverse portfolio of ready-to-use glycans, we deliver solutions that accelerate therapeutic discovery and enable innovative research.

Challenges We Help Solve

Developing glycan drug conjugates presents multiple obstacles. By offering end-to-end solutions, we help researchers and biotech companies overcome these bottlenecks and accelerate the development of innovative glycotherapeutics.

Precision and selectivity: Achieving site-specific conjugation between glycans and drug molecules without compromising biological activity.

Stability and bioavailability: Ensuring conjugates maintain structural integrity under physiological conditions for consistent therapeutic effect.

Scalability and reproducibility: Overcoming synthesis challenges to deliver conjugates suitable for both laboratory-scale research and preclinical studies.

Customization needs: Addressing unique project requirements in terms of glycan structures, linkers, and payloads.

Our Glycan Drug Conjugate Service Capabilities

We provide a full spectrum of Glycan Drug Conjugate (GDC) solutions, ensuring your project receives tailored, high-quality support from concept to delivery. Our expertise covers every critical stage of the synthesis and validation process:

01

Custom Glycan Synthesis and Modification

We design and produce a wide range of glycans, from simple monosaccharides to complex branched oligosaccharides. Depending on your research goals, we can:

  • Introduce functional groups (azides, amines, thiols) for controlled conjugation.
  • Modify glycan structures to enhance stability, solubility, or bioactivity.
  • Provide rare and non-natural glycans to explore novel therapeutic mechanisms.
02

Linker and Conjugation Strategy Design

The choice of linker and conjugation chemistry is critical for drug efficacy and release. Our team offers:

  • Stable linkers for long-lasting conjugates.
  • Cleavable linkers responsive to pH, enzymes, or redox conditions for targeted drug release.
  • Multiple conjugation chemistries (click chemistry, amide coupling, thiol-maleimide, oxime ligation) for optimal precision.
03

Payload Attachment

We can attach diverse payloads to glycans with precise control over stoichiometry and site specificity, including:

  • Therapeutic small molecules for glycan-targeted delivery.
  • Antibodies or peptides to enhance targeting and bio-distribution.
  • Fluorescent dyes or imaging agents for glycan-based probes in diagnostics.
  • Nanoparticles or polymers to create advanced glycan-drug delivery systems.
04

Analytical Characterization and Validation

Every conjugate is thoroughly validated to ensure structural accuracy and biological reliability. We use:

  • High-Performance Liquid Chromatography (HPLC) for purity analysis.
  • Mass Spectrometry (MS) for molecular weight confirmation.
  • Nuclear Magnetic Resonance (NMR) for structural characterization.
  • Stability and bioactivity assays under physiological conditions.
05

Scalable Production Support

From early-stage discovery to preclinical testing, we can scale production according to your project needs:

  • Milligram-scale synthesis for initial screening.
  • Gram-scale preparation for preclinical studies.
  • Consistent batch reproducibility with strict quality control.
06

Project Design and Consultation

We work as your partner from the start, offering:

  • Feasibility assessments for glycan-drug conjugate development.
  • Guidance on linker choice, glycan selection, and conjugation chemistry.
  • Tailored solutions to reduce cost and shorten project timelines.

Why Choose Our Services?

By choosing our Glycan Drug Conjugate service, you benefit from:

Expertise in Glycoconjugate Chemistry: Decades of combined experience in glycan synthesis, linker chemistry, and advanced bioconjugation.

End-to-End Customization: Fully tailored solutions for glycans, linkers, and payloads, ensuring optimal results for your project.

Cutting-Edge Analytical Support: Advanced instrumentation guarantees accuracy, purity, and reproducibility.

Scalability: From milligram-scale research samples to gram-scale preclinical production, we meet your evolving project needs.

Faster Turnaround Times: Streamlined workflows and in-house synthesis capabilities reduce project timelines.

Collaborative Partnership: We work closely with clients, offering scientific insights and technical support at every stage.

Application Areas of Glycan Drug Conjugate

Our Glycan Drug Conjugate service supports a wide range of applications across biomedical research and therapeutic development. Below are the key areas and how glycan conjugates add value:

Targeted Drug Delivery

  • Cell-specific targeting: Glycans can guide drug conjugates to cells expressing complementary receptors (e.g., lectins, glycan-binding proteins).
  • Improved pharmacokinetics: Glycan conjugation can extend circulation time and enhance drug bioavailability.
  • Reduced systemic toxicity: Selective targeting minimizes side effects by reducing off-target distribution.

Cancer Therapy

  • Tumor-associated glycans: Exploiting aberrant glycosylation patterns in cancer cells for selective delivery.
  • Enhanced therapeutic index: Conjugates increase the effective concentration of drugs at the tumor site.
  • Synergy with immunotherapy: Glycan-modified drugs can boost immune recognition and checkpoint inhibition.

Vaccine Development

  • Glycan-antigen conjugates: Enhance immunogenicity by presenting antigens in a more recognizable form to immune cells.
  • Adjuvant design: Glycan structures can serve as immunostimulatory adjuvants to strengthen vaccine responses.
  • Pathogen mimicry: Synthetic glycans mimic microbial glycans to elicit protective immunity.

Diagnostics and Imaging

  • Molecular probes: Glycan conjugates linked with fluorescent dyes enable tracking of biomolecular interactions.
  • Receptor mapping: Glycan imaging agents help identify glycan-receptor binding patterns in tissues.
  • Early disease detection: Glycan-based imaging conjugates improve sensitivity in cancer or infection diagnostics.

Glycobiology Research

  • Protein-glycan interaction studies: Conjugates provide tools for investigating binding specificity and affinity.
  • Cell signaling exploration: Glycan conjugates help uncover roles of glycosylation in cell communication.
  • Structure-function analysis: Modified glycans allow researchers to probe biological mechanisms.

Novel Therapeutics

  • Infectious diseases: Glycan conjugates can block pathogen adhesion or neutralize toxins.
  • Autoimmune regulation: Glycan-based drugs may modulate immune recognition and tolerance.
  • Metabolic disorders: Innovative conjugates target glycan-related pathways for therapeutic intervention.

Step-by-Step Workflow for Our Services

Our Glycan Drug Conjugate service follows a transparent, step-by-step workflow designed to ensure efficiency, quality, and project success:

Requirement Assessment and Project Planning

1Consultation & Project Assessment

Requirement Assessment and Project Planning

2Custom Design & Proposal

Requirement Assessment and Project Planning

3Glycan Synthesis & Modification

Requirement Assessment and Project Planning

4Conjugation & Payload Attachment

Requirement Assessment and Project Planning

5Analytical Validation & Quality Control

Requirement Assessment and Project Planning

6Delivery & Ongoing Support

Frequently Asked Questions (FAQs)

1. What is a Glycan Drug Conjugate (GDC)?

A Glycan Drug Conjugate is a molecule in which a drug payload is chemically linked to a glycan structure. The glycan acts as a targeting moiety or functional modifier, improving delivery, stability, or therapeutic activity.

Glycans are highly specific in their interactions with receptors and biomolecules, making them excellent targeting agents. They also enhance solubility and reduce off-target toxicity.

We can attach small molecules, peptides, proteins, antibodies, imaging agents, or nanoparticles - depending on your project's needs.

Each conjugate undergoes rigorous analytical testing (HPLC, MS, NMR, stability assays) to confirm purity, identity, and reproducibility.

Yes. We provide scalable synthesis, from milligram quantities for early research to gram quantities suitable for preclinical evaluation.

Ready to Accelerate Your Research with Glycan Drug Conjugates?

Our expertise in Glycan Drug Conjugate synthesis ensures that your project benefits from precision, reliability, and scientific innovation. Beyond custom design, we also provide access to a portfolio of ready-to-use glycans - including common structures such as sialylated glycans, fucosylated glycans, mannose derivatives, and N-acetylglucosamine analogs - which can be directly conjugated to your chosen payloads. This shortens timelines and simplifies the development process.

Contact us today to discuss your project requirements, explore custom glycan options, and begin designing the conjugates that will power your next discovery.

* Only for research. Not suitable for any diagnostic or therapeutic use.
Send Inquiry
Verification code